The board of directors of Daisho Microline Holdings Limited announced that Dr. Chan Yau Ching, Bob has been appointed as an independent non-executive director of the company and a member of the Audit Committee, the Nomination Committee and the Remuneration Committee of the Company with effect from 3 September 2018. Dr. Chan was appointed as the deputy chief executive officer and an executive director of Celestial Asia Securities Holdings Limited from November 2012 to July 2013, and later as the director of investments and corporate development from August to November 2013, where he was mainly responsible for the overall business development and the design and development of algorithm trading strategies respectively. Since January 2002, Dr. Chan has been appointed as an independent non-executive director of Lee's Pharmaceutical Holdings Limited, which principally engaged in the research, development, manufacturing and distribution of biopharmaceutical drugs in China. Since March 2014, Dr. Chan has been appointed as a managing director of KBR Capital Limited, where he is mainly responsible for asset management, advising on capital market transactions and investment management. Dr. Chan is currently a managing director and a responsible officer of KBR Fund Management Limited, which is a licenced corporation carrying out type 4 (advising on securities) and type 9 (asset management) regulated activities under the SFO. Since December 2016, Dr. Chan has been appointed as an independent non-executive director of China High Speed Transmission Equipment Group Company Limited, which principally engaged in the design, manufacturing and distribution of transmission systems for wind powered generators with customers globally. Dr. Chan was appointed as an executive director and the chief strategic officer of Celestial Asia Securities Holdings Limited from August 2002 to February 2005, and later as the investment director from November 2005 to July 2010, where he was mainly responsible for strategic investment projects and asset management.